PROPHYLAXIS OF DEEP VENOUS THROMBOSIS AND PULMONARY EMBOLISM: Current Recommendations

This publication has 70 references indexed in Scilit:

• Low-Molecular-Weight Heparin (Enoxaparin) as Prophylaxis against Venous Thromboembolism after Total Hip Replacement
  New England Journal of Medicine, 1996
• Antithrombotic Agents in Coronary Artery Disease
  Chest, 1995
• Prevention of Venous Thromboembolism
  Chest, 1995
• Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 Xal units in 2070 patients
  British Journal of Surgery, 1995
• Collaborative overview of randomised trials of antiplatelet therapy - III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients
  BMJ, 1994
• A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study
  Archives of internal medicine (1960), 1991
• Very Low Doses of Warfarin Can Prevent Thrombosis in Central Venous Catheters
  Annals of Internal Medicine, 1990
• Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosis
  British Journal of Surgery, 1988
• Prevention of Venous Thromboembolism in General Surgical Patients
  Annals of Surgery, 1988
• A Randomized Double-Blind Study Between a Low Molecular Weight Heparin Kabi 2165 and Standard Heparin in the Prevention of Deep Vein Thrombosis in General Surgery
  Thrombosis and Haemostasis, 1988